Eflornithine
Ornidyl, Vaniqa (eflornithine) is a small molecule pharmaceutical. Eflornithine was first approved as Ornidyl on 1990-11-28. It is used to treat african trypanosomiasis, hypertrichosis, and protozoan infections in the USA. It has been approved in Europe to treat hirsutism. The pharmaceutical is active against ornithine decarboxylase.
| Trade Name | Vaniqa |
|---|---|
| Common Name | Eflornithine |
| Indication | african trypanosomiasis, hirsutism, hypertrichosis, protozoan infections |
| Drug Class | Fc fusion protein |
